August 31, 2017 / 2:28 PM / a year ago

Daiichi Sankyo denies receiving takeover bid from AstraZeneca

LONDON (Reuters) - Japan’s Daiichi Sankyo denied on Thursday it had received a takeover bid last year from British drugmaker AstraZeneca, as reported earlier by the online version of Nikkei Business.

“This is not the fact,” the company said in a short statement.

AstraZeneca had earlier declined to comment on the report, which sent the Japanese group’s share price soaring as much as 13 percent and triggered a trade suspension.

Reporting by Ben Hirschler; Editing Martinne Geller

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below